Co-Diagnostics Inc (NASDAQ:CODX) shares reached a new 52-week low during trading on Friday . The company traded as low as $1.01 and last traded at $1.13, with a volume of 1563 shares traded. The stock had previously closed at $1.16.
A hedge fund recently raised its stake in Co-Diagnostics stock. Vanguard Group Inc grew its position in shares of Co-Diagnostics Inc (NASDAQ:CODX) by 18.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 95,342 shares of the company’s stock after purchasing an additional 15,027 shares during the period. Vanguard Group Inc’s holdings in Co-Diagnostics were worth $251,000 as of its most recent SEC filing.
WARNING: “Co-Diagnostics (CODX) Reaches New 52-Week Low at $1.01” was posted by Macon Daily and is the sole property of of Macon Daily. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The legal version of this piece can be viewed at https://macondaily.com/2019/01/11/co-diagnostics-codx-reaches-new-52-week-low-at-1-01.html.
About Co-Diagnostics (NASDAQ:CODX)
Co-Diagnostics, Inc, a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics, Inc was founded in 2013 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Co-Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Co-Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.